What Is an Osteochondral Lesion of the Talar Dome?

An osteochondral lesion of the talar dome (OLT) — formerly called osteochondritis dissecans — is an injury to the articular cartilage and underlying subchondral bone of the talus, most commonly at the medial or lateral dome (the superior surface of the talus that articulates with the tibia). OLTs cause deep ankle pain, swelling, stiffness, and sometimes mechanical symptoms (catching, locking) from loose cartilage fragments. They are most often caused by acute ankle trauma — approximately 70% follow an ankle sprain — but can result from repetitive microtrauma or avascular necrosis. The key clinical challenge: OLTs are frequently missed in the early weeks after ankle sprain because standard X-rays often appear normal at initial presentation, and persistent “ankle sprain” pain that is not resolving at 6–8 weeks should trigger MRI evaluation for OLT. At Balance Foot & Ankle in Howell and Bloomfield Hills, Michigan, Dr. Tom Biernacki, DPM evaluates OLTs. Call (810) 206-1402.

Staging and What It Means for Treatment

OLTs are staged using MRI (Hepple classification) or CT (Berndt and Harty): Stage I — subchondral bone compression, intact cartilage; Stage II — partially detached fragment, stable; Stage III — completely detached fragment, still in place (non-displaced); Stage IV — displaced fragment; Stage V — subchondral cyst. Stages I–II have good nonoperative potential (50–75% healing with conservative management). Stages III–V have poor nonoperative response and typically require surgical intervention. Lesion size matters: OLTs >15mm² have lower nonoperative success rates than smaller lesions, regardless of stage.

Nonoperative Management — Who Qualifies and How

Nonoperative management is appropriate for Stage I–II OLTs and for initial management of Stage III lesions in skeletally immature patients (open growth plates): non-weight-bearing cast or cam boot for 6–8 weeks to offload the talar dome and allow subchondral bone remodeling; followed by gradual return to weight-bearing with an ankle brace for proprioceptive support; custom orthotics to reduce tibiotalar joint stress during recovery; physical therapy for proprioceptive retraining and peroneal strengthening; and 3–6 month activity restriction from impact sports. Serial MRI at 3 and 6 months monitors healing progress. Nonoperative management achieves complete healing in 45–50% of Stage I–II lesions — a significant proportion, justifying the conservative trial before surgical commitment.

Biological Injections — Emerging Adjunct Therapy

Platelet-rich plasma (PRP) and hyaluronic acid injections into the ankle joint are increasingly used as adjuncts to nonoperative management for OLTs: intra-articular PRP provides growth factor concentrations that stimulate chondrocyte activity and subchondral bone remodeling — emerging clinical evidence shows improved MRI healing rates in Stage I–III lesions treated with combined PRP and immobilization versus immobilization alone; hyaluronic acid provides joint lubrication that reduces mechanical cartilage stress during the healing period. These are not replacements for appropriate weight-bearing restriction but may improve healing rates in lesions that are borderline for nonoperative management.

When Surgery Is Required — Arthroscopic Drilling and OATS

Failed nonoperative management or Stage III–V lesions typically require surgical intervention: arthroscopic bone marrow stimulation (drilling or microfracture) for lesions <15mm² — creates bleeding channels that form fibrocartilage repair tissue; osteochondral autograft transfer system (OATS) for lesions 15–25mm² — transplants a cartilage-bone plug from a non-weight-bearing knee area to the talar defect; allograft OAT for larger defects; and DeNovo juvenile cartilage graft or autologous chondrocyte implantation (ACI) for large or salvage cases. Recovery varies: arthroscopic drilling 3–4 months; OATS 6–9 months to full athletic activity.

OLT Management in Howell & Bloomfield Hills Michigan

Dr. Tom Biernacki, DPM evaluates osteochondral talar dome lesions with weight-bearing X-rays, MRI coordination, and weight-bearing CT when needed at Balance Foot & Ankle. Nonoperative management protocols and PRP injection are available in-office. Surgical consultation for failed conservative management is provided. Serving Howell, Brighton, Bloomfield Hills, Troy, Auburn Hills, and all Southeast Michigan. Book your evaluation or call (810) 206-1402.

Dr. Tom Biernacki, DPM

Dr. Tom Biernacki, DPM is a double board-certified podiatrist and foot & ankle surgeon at Balance Foot & Ankle Specialists in Southeast Michigan. With over a decade of clinical experience, he specializes in heel pain, bunions, diabetic foot care, sports injuries, and minimally invasive surgery. Dr. Biernacki is a member of the APMA and ACFAS, and his patient education content on MichiganFootDoctors.com and YouTube has reached over one million views.